Insight Molecular Diagnostics Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Insight Molecular Diagnostics Inc. (IMDX) reported Cash and Cash Equivalents, Period Increase (Decrease) of $31.22 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-14.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-14
- Insight Molecular Diagnostics Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $31.22M, a 522.96% increase year-over-year.
- Insight Molecular Diagnostics Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$2.79M.
- Insight Molecular Diagnostics Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $527.00K, a 77.86% decline year-over-year.
- Insight Molecular Diagnostics Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$2.32M.
- Insight Molecular Diagnostics Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $434.00K.
- Insight Molecular Diagnostics Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$2.57M, a 218.18% decline from fiscal 2016.
- Insight Molecular Diagnostics Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $2.18M, a 71.86% decline from fiscal 2015.
- Insight Molecular Diagnostics Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $7.74M, a 4860.90% increase from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-03-31 | $31.22M 10-Q · filed 2019-05-14 | $28.44M derived: sum of 2 quarters · filed 2019-05-14 | $28.96M derived: sum of 3 quarters · filed 2019-05-14 | $26.64M derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-12-31 | -$2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$2.26M derived: sum of 2 quarters · filed 2019-04-01 | -$4.58M derived: sum of 3 quarters · filed 2019-04-01 | $434.00K 10-K · filed 2019-04-01 |
| 2018-09-30 | $527.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$1.79M derived: sum of 2 quarters · filed 2018-11-13 | $3.22M 10-Q · filed 2018-11-13 | -$203.00K derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-06-30 | -$2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $2.69M 10-Q · filed 2018-08-14 | -$730.00K derived: sum of 3 quarters · filed 2019-05-14 | $1.65M derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-03-31 | $5.01M 10-Q · filed 2019-05-14 | $1.59M derived: sum of 2 quarters · filed 2019-05-14 | $3.97M derived: sum of 3 quarters · filed 2019-05-14 | $1.26M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | -$3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$1.04M derived: sum of 2 quarters · filed 2019-04-01 | -$3.75M derived: sum of 3 quarters · filed 2019-04-01 | -$2.57M 10-K · filed 2019-04-01 |
| 2017-09-30 | $2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$328.00K derived: sum of 2 quarters · filed 2018-11-13 | $850.00K 10-Q · filed 2018-11-13 | -$1.65M derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | -$2.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$1.53M 10-Q · filed 2018-08-14 | -$4.03M derived: sum of 3 quarters · filed 2018-08-14 | $4.64M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $1.18M 10-Q · filed 2018-05-15 | -$1.32M derived: sum of 2 quarters · filed 2018-05-15 | $7.35M derived: sum of 3 quarters · filed 2018-05-15 | $5.50M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $6.17M derived: sum of 2 quarters · filed 2018-04-02 | $4.32M derived: sum of 3 quarters · filed 2018-04-02 | $2.18M 10-K · filed 2018-04-02 |
| 2016-09-30 | $8.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $6.82M derived: sum of 2 quarters · filed 2017-11-14 | $4.68M 10-Q · filed 2017-11-14 | $3.26M derived: sum of 4 quarters · filed 2018-04-02 |
| 2016-06-30 | -$1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$4.00M 10-Q · filed 2017-08-14 | -$5.41M derived: sum of 3 quarters · filed 2018-04-02 | $1.60M derived: sum of 4 quarters · filed 2018-04-02 |
| 2016-03-31 | -$2.14M 10-Q · filed 2017-04-28 | -$3.55M derived: sum of 2 quarters · filed 2018-04-02 | $3.46M derived: sum of 3 quarters · filed 2018-04-02 | $5.77M derived: sum of 4 quarters · filed 2018-04-02 |
| 2015-12-31 | -$1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $5.60M derived: sum of 2 quarters · filed 2018-04-02 | $7.91M derived: sum of 3 quarters · filed 2018-04-02 | $7.74M 10-K · filed 2018-04-02 |
| 2015-09-30 | $7.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $9.33M derived: sum of 2 quarters · filed 2016-11-10 | $9.15M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $2.14M 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | -$175.00K 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | $156.00K 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |